TFAM and ovarian carcinoma: At cellular basis, decreased TFAM and mtDNA content led to lower mitochondrial activity resulting in greater lactate production, increased cell proliferation and enhanced metastatic capacity in breast cancer [23], intestinal cancer [24], oesophageal cancer [20], and cisplatin (CDDP) resistant ovarian cancer [19].